Bookmark Article
Bankrupt genetic testing firm 23andMe Holding Co. has been granted permission to sell customers’ medical and ancestry data, its most valuable asset, amid concerns over privacy and safety. The company’s shares surged on the news, with a deadline set for potential bidders by May 7. US Bankruptcy Judge Brian C. Walsh has required a two-week extension on the sale process to allow for creditor input and ensure a fair decision.
Full Article
